566 Results
Sort By:
Published on January 10, 2018
As is its custom, San Diego-based next-gen sequencing (NGS) giant Illumina made a splash at the JP Morgan Healthcare Conference in San Francisco with its new, pint-sized, benchtop instrument, the iSeq 100 introduced by company CEO Francis deSouza, the successor to Jay Flatley who now serves as executive chairman. The…
Published on January 5, 2018
Scientists based at MRC Laboratory of Molecular Biology, Cambridge, U.K., using mouse models to show how alcohol exposure leads to permanent genetic damage, have found that acetaldehyde, an endogenous and alcohol-derived metabolite, can break and damage DNA within blood stem cells. While alcohol isn't currently consider causitive for blood cancers,…
Published on January 2, 2018
DNAnexus, the developer of a cloud-based genome informatics and data management platform, said today it has closed on a $58 million financing intended to accelerate the company’s expansion in translational informatics, clinical trials, and broadened use of biomedical data. New investor Foresite Capital led the equity financing, with strategic investment…
Published on December 12, 2017
Small differences in the genetic codes of individuals could significantly impact the efficacy, side effects and safety of treatments created via CRISPR/Cas9 gene editing according to researchers at Harvard Medical School, Boston Children’s Hospital, and the Université de Montréal. Their findings suggest that a one-size-fits-all approach to therapeutic gene editing…
Published on December 1, 2017
Sponsor: Illumina The NovaSeq S4 flow cell reagent kit and NovaSeq Xp workflow, for its NovaSeq™ 6000 System, extend the capabilities of the NovaSeq platform to enable high-intensity sequencing across a wide range of sequencing methods. NovaSeq S4 flow cell delivers up to 6TB of output in two days and…
Published on November 17, 2017
llumina executive chairman Jay Flatley used the mantle of receiving the Lifetime Acheivement Award at the Pesonalized Medicine Conference November 15, to frame his view of personalized medicine around the them of “shock and awe” in a keynote address. “I’m in awe of what we’ve accomplished [in genomic medicine],” he…
Published on November 6, 2017
Seven Bridges said today it has been selected by the NIH to lead a public-private consortium that will develop the pilot phase of a new data ecosystem for the agency. The Data Commons Pilot Phase is NIH’s latest effort to accelerate biomedical research through informatics, with the goal of advancing…
Published on November 3, 2017
Investigators at The University of Texas MD Anderson Cancer Center and other institutions have just released new data describing how bacteria that reside in the human digestive tract can influence how melanoma responds to immunotherapy, indicating that a probiotic regimen could aid patients receiving an anti-PD-1 immunotherapy for melanoma. Findings…
Published on October 26, 2017
Precision medicine based on tumor-only sequencing is more precise for people of European decent—and less precise for those whose ancestry is from Latin America, Africa and Asia, according to a study. Researchers from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and the Keck School of…
Published on October 20, 2017
Following are further product and service announcements made at the American Society of Human Genetics 2017 Annual Meeting, held Oct. 17-21 in Orlando, FL. CombiMatrix Presents Data from Genomic Abnormalities Study CombiMatrix presented new data at ASHG from a large-scale, first-of-its kind study showing that genomic alterations decrease in frequency…
Published on October 19, 2017
Thermo Fisher Scientific said today it has partnered with The Wellcome Trust Sanger Institute to co-develop the Applied Biosystems Axiom Africa Array, designed to capture genome-wide variation in African populations, as well as Asian and European populations. The Array, which uses the Axiom genotyping technology of Thermo Fisher’s Applied Biosciences…
Published on September 13, 2017
A controversial study published last week in the Proceedings of the National Academy of Sciences (PNAS) by researchers from Human Longevity Inc. (HLI), the San Diego company cofounded by J. Criag Venter, which said they could scour an individual’s genome sequence and predict a handful of physical traits—including facial structure—has…
Published on August 25, 2017
DNAnexus and Saphetor said they will partner to build a sample-in, report-out genomic analysis solution designed to advance precision medicine by combining their technologies. The solution will combine DNAnexus’ cloud-based platform with Saphetor’s technology, designed to let users annotate and classify genetic variants from next-generation sequencing (NGS) data. Saphetor’s genome…
Published on August 14, 2017
A team of investigators from Stanford University has just released data on their efforts to develop a new iquid biopsy test that can detect genetic mutations in minute amounts of DNA released from cancer cells into the blood using a relatively simple PCR-based assay. The results from this study—published…
Published on August 4, 2017
A landmark study, published in Nature on August 2, 2017, has described the first timein the U.S. that CRISPR was used to repair a germline mutation in human embryos created through in vitro fertilization. The study was a collaboration between the Salk Institute, Oregon Health and Science University (OHSU), and…